• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vitro Diagnostics

Vitro Diagnostics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B.R.A.H.M.S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

    bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B.R.A.H.M.S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

  2. Global Companion Diagnostics Strategic Business Report 2016 - Analysis & Forecasts 2015-2022 - Research and Markets

    Global Companion Diagnostics Strategic Business Report 2016 - Analysis & Forecasts 2015-2022 - Research and Markets

  3. Global Companion Diagnostics Market Analysis & Trends Report 2016 - Industry Forecast to 2025 - Research and Markets

    Global Companion Diagnostics Market Analysis & Trends Report 2016 - Industry Forecast to 2025 - Research and Markets

  4. World Market for Companion Diagnostic Tests 2015-2020 - Research and Markets

    World Market for Companion Diagnostic Tests 2015-2020 - Research and Markets

  5. Demand for Personalized Medicines to Create Opportunities for the Global Cancer Diagnostics Device Market Through 2020, Reports Technavio

    Demand for Personalized Medicines to Create Opportunities for the Global Cancer Diagnostics Device Market Through 2020, Reports Technavio

  6. North America In-Vitro Diagnostic Testing Services Market Trends and Forecasts 2016-2019 - Research and Markets

    North America In-Vitro Diagnostic Testing Services Market Trends and Forecasts 2016-2019 - Research and Markets

  7. bioMérieux Acquires Hyglos and Expands Its Offering to the Detection of Endotoxins in Pharmaceutical Products

    bioMérieux Acquires Hyglos and Expands Its Offering to the Detection of Endotoxins in Pharmaceutical Products

  8. Roche Builds a Wide Moat With Dominant Oncology and Diagnostics Franchises

    Firm has a promising strategy of combining expertise in both areas to generate a growing personalized medicine pipeline.

  9. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.